Should We Charge Patients for Medical Research?

NYT Health, 31 July 2015
Authors: Ezekiel J Emanuel, Steven Joffe
“This idea is not as outlandish as it sounds. In the 1980s some for-profit companies and institutes charged patients for participating in research. Mostly they went bust. Recently, others have proposed that the rich buy places in clinical trials. And now scientists have begun thinking this may be a way to fund promising research ideas. By charging participants, maybe a few experimental tests and treatments that would not be pursued under today’s tight research budgets would be funded, and maybe one or two would succeed. But the risks are not worth taking. We must avoid compromising the integrity of the entire research enterprise and the likelihood of exploitation that will inevitably accompany pay-to-play trials.”
Find article here.